Ticho Barry 4

What Happened
Ticho Barry, Chief Medical Officer of Stoke Therapeutics (STOK), sold 1,795 shares in an open-market transaction on June 1, 2026. The shares were disposed at $30.58 per share for a total transaction value of $54,891. This was a sale (not a purchase), which is often routine insider liquidity rather than an explicit signal about company prospects.

Key Details

• Transaction date: 2026-06-01
• Transaction type/code: Open-market sale (S)
• Price per share: $30.58
• Shares sold: 1,795
• Total value: $54,891
• Footnote: Executed pursuant to a Rule 10b5-1 trading plan adopted November 19, 2025.
• Shares owned after transaction: Not specified in the supplied filing details.
• Filing timeliness: Form filed 2026-06-03 for a 2026-06-01 transaction — appears to be timely (no late filing flag reported).

Context
Rule 10b5-1 plans allow insiders to sell pre-specified amounts at predetermined times and are commonly used to avoid concerns about trading on inside information. Sales under such plans are typically considered routine; they do not by themselves indicate the insider’s current view of the company’s prospects.